Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01248104 · ClinicalTrials.gov registry record · NA
Comparison of Tranexamic to Epsilon Aminocaproic Acid: a Prospective Analysis of Blood Conservation in Cardiac Surgery
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT01248104 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 100 participants.
The verdict
NCT01248104, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
We designed a prospective double-blinded randomized trial in an attempt to detect a difference between tranexamic acid (TXA) and epsilon aminocaproic acid (EACA) in reducing transfusion in patients undergoing cardiac surgery.
Interventions
- DRUG Tranexamic Acid
- DRUG Aminocaproic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2010-03 |
| Est. Completion | 2015-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01248104
The ClinicalTrials.gov registry entry for NCT01248104 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tranexamic Acid is the first listed.
NCT01248104 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01248104 about?
NCT01248104 is a clinical study titled "Comparison of Tranexamic to Epsilon Aminocaproic Acid: a Prospective Analysis of Blood Conservation in Cardiac Surgery". We designed a prospective double-blinded randomized trial in an attempt to detect a difference between tranexamic acid (TXA) and epsilon aminocaproic acid (EACA) in reducing transfusion in patients undergoing cardiac surgery.
What is the current status of trial NCT01248104?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2010-03. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01248104?
The interventions under investigation include: Tranexamic Acid (DRUG), Aminocaproic Acid (DRUG).
Who is sponsoring clinical trial NCT01248104?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.